no more tirzepatide In adults with obesity but not diabetes, leads to significantly greater weight loss than semaglutide over 72 weeks, and nearly double the patients on tirzepatide meet the 25% weight-loss target. http://ms.spr.ly/6183SkuIL Eli Lilly launched a four-dose,

This is especially important for people with active cancer, a history of cancer, or anyone receiving cancer treatment, since NACs relationship with cancer biology is complicated

Novo Nordisk - Regulatory Approval (December 2025): FDA approved the first oral GLP-1 for weight loss-Novo Nordisk's once-daily semaglutide pill-which launched in January 2026 [3]

This approach ensures that comparisons within each subgroup account for potential confounding while avoiding assumptions of a uniform interaction effect across all groups

hGLP-1, pGLP-1, eGLP-1 and Ex-4 (7 M) were incubated with purified human serum in 37 C incubator in the presence/absence of 100 M of DPP-4 inhibitor P32/98 (Santa Cruz Biotech), and aliquots of the reaction solutions were extracted after 0, 3, 6, 9 and 11 h incubation respectively, when TFA (0.1%) was added to terminate the reactions

Ro big advantage is insurance coordination

If the sublingual form proves to be as effective or even more convenient than injections, it could become a preferred choice for many patients